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Abstract
Prion diseases are characterised by the accumulation of PrPSc, an abnormally folded isoform of the cellular prion protein
(PrPC), in affected tissues. Following peripheral exposure high levels of prion-specific PrPSc accumulate first upon follicular
dendritic cells (FDC) in lymphoid tissues before spreading to the CNS. Expression of PrPC is mandatory for cells to sustain
prion infection and FDC appear to express high levels. However, whether FDC actively replicate prions or simply acquire
them from other infected cells is uncertain. In the attempts to-date to establish the role of FDC in prion pathogenesis it was
not possible to dissociate the Prnp expression of FDC from that of the nervous system and all other non-haematopoietic
lineages. This is important as FDC may simply acquire prions after synthesis by other infected cells. To establish the role of
FDC in prion pathogenesis transgenic mice were created in which PrPC expression was specifically ‘‘switched on’’ or ‘‘off’’
only on FDC. We show that PrPC-expression only on FDC is sufficient to sustain prion replication in the spleen. Furthermore,
prion replication is blocked in the spleen when PrPC-expression is specifically ablated only on FDC. These data definitively
demonstrate that FDC are the essential sites of prion replication in lymphoid tissues. The demonstration that Prnp-ablation
only on FDC blocked splenic prion accumulation without apparent consequences for FDC status represents a novel
opportunity to prevent neuroinvasion by modulation of PrPC expression on FDC.
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Introduction
Prion diseases (Transmissible spongiform encephalopathies;
TSE) are sub-acute neurodegenerative diseases that affect both
humans and animals. Many prion diseases, including natural
sheep scrapie, bovine spongiform encephalopathy, chronic wasting
disease in mule deer and elk, and kuru and variant Creutzfeldt-
Jakob disease in humans, are acquired by peripheral exposure (eg:
orally or via lesions to skin or mucous membranes). After
peripheral exposure prions accumulate first upon follicular
dendritic cells (FDC) as they make their journey from the site of
infection to the CNS (a process termed, neuroinvasion) [1–7]. FDC
are a unique subset of stromal cells resident within the primary B
cell follicles and germinal centres of lymphoid tissues [8]. Prion
accumulation upon FDC is critical for efficient disease pathogen-
esis as in their absence neuroinvasion are impaired [1–4]. From
the lymphoid tissues prions invade the CNS via the peripheral
nervous system [9].
During prion disease aggregations of PrPSc, an abnormally
folded isoform of the cellular prion protein (PrPC) accumulate in
affected tissues. Prion infectivity co-purifies with PrPSc [10] and is
considered to constitute the major, if not sole, component of
infectious agent [11]. Host cells must express cellular PrPC to
sustain prion infection [12] and FDC appear to express high levels
of PrPC on the cell membrane in uninfected mice [13,14].
Although prion neuroinvasion from peripheral sites of exposure is
dependent upon the presence of FDC in lymphoid tissues, it is not
known whether FDC actually replicate prions themselves. FDC
characteristically trap and retain native antigen on their surfaces
for long periods in the form of immune complexes, consisting of
antigen-antibody and/or complement components. Prions are also
considered to be acquired by FDC as complement-opsonized
immune complexes [15–18]. Thus, during prion infection FDC
might simply trap and retain PrPSc-containing immune complexes
on their surfaces following synthesis by other infected cells such as
neurones.
Many cell types including classical DC, lymphocytes, mast cells,
platelets, reticulocytes and epithelial cells secrete membrane
vesicles termed exosomes that are enriched in cell-specific protein
[19,20]. Although the functions of exosomes are uncertain FDC
can bind them on their surfaces. These microvesicles permit FDC
to passively acquire and display proteins on their surfaces that they
do not express at the mRNA level [21]. Studies have shown that
prions only accumulated in the spleens of mice in which the FDC-
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containing stromal compartment expressed PrPC [13,14]. How-
ever, in each of those studies it was not possible to dissociate the
Prnp expression status of the FDC from that of the nervous system
and all other host-derived non-haematopoietic and stromal cell
populations [13,14,22]. This is important as prion infection can
occur within inflammatory PrPC-expressing stromal cells that are
distinct from FDC [23]. Furthermore, as both PrPC and PrPSc can
be released from cells in association with exosomes [20] FDC may
passively acquire PrPC and prions after release in exosomes from
other infected cells [24,25].
No therapies are available to treat prions diseases. A thorough
characterization of the host cells that are infected by prions is
imperative for the identification of candidate molecular targets for
therapeutic intervention, the development of useful pre-clinical
diagnostics and to aid our understanding of the risk of
transmission. To definitively determine the role of FDC in prion
pathogenesis, two unique compound transgenic mouse models
were created in which PrPC expression was specifically ‘‘switched
on’’ or ‘‘switched off’’ only on FDC. These mice were then used to
establish: i) whether FDC express PrPC or simply acquire it from
other host cells; and ii) whether FDC amplify prions, or simply
acquire them from other infected host cells. Our data clearly show
that PrPC-expressing FDC alone are sufficient to sustain prion
replication in the spleen. Furthermore, prion replication in the
spleen is blocked in mice in which PrPC-expression is specifically
ablated only on FDC.
Results
Mice expressing Cre recombinase specifically in FDC
To study FDC-specific gene function transgenic mice were
used that expressed Cre recombinase under the control of the Cr2
locus (CD21-Cre mice) which directs expression in FDC and
mature B cells [26,27]. First the cellular specificity of the Cre
recombination was assessed by crossing the CD21-Cre mice with
the ROSA26flox/flox reporter strain [28]. Histological analysis
showed efficient LacZ expression indicative of Cre-mediated gene
recombination in FDC and B cell follicles in the spleens, lymph
nodes and Peyer’s patches of CD21-Cre ROSA26flox/flox mice
(Figure 1A, B). No recombination was observed in FDC and
mature B cells in the spleens of ROSA26flox/flox reporter mice that
lacked Cre expression (Figure 1B). Unlike lymphocytes, FDC do
not derive from bone marrow precursors [29]. As a consequence,
it is possible to mix-and-match the genotype of FDC and
lymphocytes by grafting bone marrow cells from donor mice into
recipients of a different genetic background [13,14,22]. To restrict
Cre-expression to FDC, adult CD21-Cre ROSA26flox/flox mice
were lethally c-irradiated and 24 h later reconstituted with bone
marrow from Cre-deficient C57BL/6 wild-type (WT) mice
(termed WTRCD21-Cre ROSA26flox/flox mice) and tissues from
six mice from each group analysed 100 days after transfusion.
Using this approach, in these mice all B cells lack Cre-expression
as they derive from the WT donor bone marrow, whereas the
FDC express Cre as they are host-derived. Analysis of the cellular
sites of LacZ expression in WTRCD21-Cre ROSA26flox/flox mice
confirmed that Cre-mediated recombination was associated with
FDC (Figure 1B). No other cellular sites of Cre-mediated
recombination were observed in the spleens of WTRCD21-Cre
ROSA26flox/flox mice. Furthermore, no other cellular sites of Cre-
mediated recombination were observed in a wide range of non-
lymphoid peripheral tissues from CD21-Cre ROSA26flox/flox and
WTRCD21-Cre ROSA26flox/flox (heart, liver, kidney, pancreas,
ear, tongue, skeletal, muscle, ovary, uterus, bladder, testes,
epididymis, sciatic nerve and spinal cord; data not shown). These
data clearly demonstrate that CD21-Cre mice are a useful tool to
study FDC-specific gene expression and function.
Expression of Cre recombinase by the Cr2 promoter is
not toxic to FDC
Cre toxicity can occur in some Cre transgenic mouse lines
whereby Cre recombinase causes mis-recombination, DNA
damage and death of Cre-expressing cells [30]. However,
immunohistochemical (IHC) analysis of spleens from CD21-Cre
ROSA26flox/flox mice and WTRCD21-Cre ROSA26flox/flox mice
showed no significant effect of Cre-expression on the status of
FDC networks and B cell follicles when compared to spleens from
WT control mice and ROSA26flox/flox mice that lacked Cre
expression (Figure 1C). Furthermore, the expression of Cre
recombinase under the control of the Cr2 locus had no observable
effect on CD21/35 expression (Figure 1C).
FDC express Prnp and do not acquire PrPC from
neighbouring cells
Next, mice were created in which Prnp expression (which
encodes PrPC) was restricted only to FDC. To do so, CD21-Cre
mice were first bred onto a PrPC-deficient (Prnp-/-) background.
The resulting CD21-Cre Prnp-/- mice were then crossed with
Prnpstop/- mice in which a floxed b-geo stop cassette was inserted
into intron 2 of the Prnp gene upstream of exon 3 [31]. In the
progeny CD21-Cre Prnpstop/- mice, PrPC is only expressed in cells
expressing Cre recombinase (CD21-expressing FDC and mature B
cells). To restrict the Prnp-expression to FDC, CD21-Cre Prnpstop/-
mice were lethally c-irradiated and grafted with bone marrow
from Cre-deficient Prnpstop/- mice (Prnpstop/-RCD21-Cre Prnpstop/-
mice). We also performed bone marrow transfers from CD21-Cre
Prnpstop/- donors into CD21-Cre Prnpstop/- recipients (CD21-Cre
Prnpstop/-RCD21-Cre Prnpstop/- mice), CD21-Cre Prnpstop/- donors
into Cre-deficient Prnpstop/- mice (CD21-Cre Prnpstop/-RPrnpstop/-
mice) and Prnp+/- donors into Prnp+/- recipients (Prnp+/-RPrnp+/-
mice) as controls (Figure 2A).
Spleens, tails and blood from six mice from each group were
examined 100 days after bone marrow transfusion. PCR analysis
of DNA isolated from the tails, blood and spleens of mice in each
group was used to confirm the presence of Cre (Figure 2B, upper
panel) and Cre-mediated DNA recombination (Figure 2B, lower
panel) within the stromal, haematopoietic or both compartments
(respectively). The detection of Cre in the tail and spleen but not
Author Summary
Prion diseases are infectious neurological disorders and are
considered to be caused by an abnormally folded
infectious protein termed PrPSc. Soon after infection prions
accumulate first upon follicular dendritic cells (FDC) in
lymphoid tissues before spreading to the brain where they
cause damage to nerve cells. Cells must express the
normal cellular prion protein PrPC to become infected with
prions. However, whether FDC are infected with prions or
simply acquire them from other infected cells is unknown.
To establish the role of FDC in prion disease PrPC
expression was specifically ‘‘switched on’’ or ‘‘off’’ only
on FDC. We show that PrPC-expressing FDC alone are
sufficient to sustain prion replication in the spleen.
Furthermore, prion replication is blocked in the spleen
when PrPC-expression is switched off only on FDC. These
data definitively demonstrate that FDC are the essential
sites of prion replication in lymphoid tissues.
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Figure 1. Cre-mediated gene recombination in FDC in the spleens, lymph nodes and Peyer’s patches of CD21-Cre ROSA26flox/Flox
mice. A) Analysis of the cellular sites of LacZ expression (blue) in the spleens, inguinal lymph nodes, Peyer’s patches and mesenteric lymph nodes of
CD21-Cre ROSA26flox/flox mice shows Cre-mediated recombination in a focus of cells within the B cell follicles. Sections were counterstained with
nuclear fast red (red). B) IHC analysis of FDC (CD35+ cells, upper row, red) and B cells (CD45R+ cells, lower row, red) confirmed that Cre-mediated LacZ
expression (blue) was associated with FDC in the spleens of WTRCD21-Cre ROSA26flox/flox mice. No LacZ expression was associated with FDC in
spleens from ROSA26flox/flox mice that lacked Cre. C) IHC analysis of the status of FDC (CD35+ and C4-binding cells; red) and B cells expressing CD45R,
CD19, and CD1d (red) in spleens from WT, CD21-Cre ROSA26flox/flox, WTRCD21-Cre ROSA26flox/flox and ROSA26flox/flox mice. Scale bars 100 mm. n=6
mice/group.
doi:10.1371/journal.ppat.1002402.g001
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Figure 2. FDC-restricted PrPc expression in the spleens of Prnpstop/-RCD21-Cre Prnpstop/- mice. A) The anticipated distribution of PrPC
expression on FDC and B cells in tissues from each mouse group. B) The detection of Cre in the tail and spleen but not blood of the Prnpstop/-RCD21-
Cre Prnpstop/- mice confirmed the restriction of the Cre-expression to the stromal but not haematopoietic compartments of these mice (upper panel).
Efficient Cre-mediated recombination of Prnpstop (Prnpstop(R)) was restricted to the FDC-containing stromal compartment of the spleens of
Prnpstop/-RCD21-Cre Prnpstop/- mice when compared to control mice. Cre-mediated recombination by CD21-expressing lymphocytes was efficiently
prevented in these mice by the irradiation and transfer of Prnpstop/- bone marrow as demonstrated by the lack of a Prnpstop(R) band in DNA extracted
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blood of the Prnpstop/-RCD21-Cre Prnpstop/- mice confirmed the
restriction of the Cre-expression to the stromal but not haemato-
poietic compartments of these mice. In addition, PCR analysis also
confirmed that in these mice efficient Cre-mediated recombination
of the Prnpstop/- allele was restricted to the FDC-containing stromal
compartment of the spleen (Figure 2B). In Prnpstop/-RCD21-Cre
Prnpstop/- mice the recombined Prnpstop/- allele (Prnpstop(R)) was
detected in the spleen, but not blood and tail. Thus these data
indicate that in the spleens of Prnpstop/-RCD21-Cre Prnpstop/- mice
Cre-mediated recombination is restricted to FDC and not B cells.
As anticipated, in the spleens of Prnp+/-RPrnp+/- control mice
high levels of PrPC expression were observed upon FDC and
tyrosine hydroxylase (TH)-positive sympathetic nerves (Figure 2C).
In contrast, in the spleens of Prnpstop/-RCD21-Cre Prnpstop/- mice
PrPC was only expressed on FDC (Figure 2C). In the absence of
Cre-recombinase expression by FDC and peripheral nerves in
CD21-Cre Prnpstop/-RPrnpstop/- mice, PrPC expression was not
expressed by either cell population (Figure 2C).
Morphometric analysis confirmed that the amount of the PrPC
expression co-localized upon the surfaces of FDC in the spleens of
Prnpstop/-RCD21-Cre Prnpstop/- mice was not significantly different
from that observed upon FDC in spleens from Prnp+/-RPrnp+/-
control mice (P,0.69, n= 48 FDC/group; Figure 2D). In contrast,
in the absence of Cre-recombinase expression by FDC in CD21-
Cre Prnpstop/-RPrnpstop/- mice, PrPC expression was substantially
lower than that observed upon FDC in spleens from
Prnp+/-RPrnp+/- control mice (P,1610-25, n= 48; Figure 2D).
Morphometric analysis also confirmed that PrPC expression upon
the surfaces of sympathetic nerves in the spleens of
Prnpstop/-RCD21-Cre Prnpstop/-, CD21-Cre Prnpstop/-R CD21-
Cre Prnpstop/- and CD21-Cre Prnpstop/-RPrnpstop/- mice was
significantly ablated when compared to that observed upon
sympathetic nerves in spleens from Prnp+/-RPrnp+/- control mice
(p,1610225, n= 48 sympathetic nerves/group). Together, these
data confirm that in the spleens of Prnpstop/-RCD21-Cre Prnpstop/-
mice PrPC expression is specifically restricted to FDC, whereas in
spleens from CD21-Cre Prnpstop/-RPrnpstop/- mice, FDC lack PrPC
expression. FDC can passively acquire the expression of some
surface molecules including MHC class II and complement
component C4 [21,32]. However, these data confirm that FDC
express high levels of cellular PrPC on their surfaces and do not
simply acquire it from neighbouring cells.
IHC analysis confirmed that the microarchitecture (Figure 3A),
size (P= 0.755, n= 32; Figure 3B) and number (P= 0.249, n= 32;
Figure 3C) of the FDC networks in spleens from mice with Prnp-
expression restricted to FDC (Prnpstop/-RCD21-Cre Prnpstop/-
mice) were normal when compared to control mice. Other studies
have shown that the density of sympathetic nerves can significantly
influence the amount of prion accumulation within in the spleen
[33]. Quantitative analysis of the relative positioning of FDC and
sympathetic nerves showed there were no significant differences in
average distance between these cell populations in spleens from
each mouse group (Figure 3D & E; P,0.932, n= 48).
FDC-restricted PrPC-expression is sufficient to sustain
prion replication in the spleen
Next, we determined the effect of FDC-restricted Prnp-
expression on prion replication in the spleen. In this study, the
normal cellular form of the prion protein is referred to as PrPC,
and two distinct terms (PrPSc or PrPd) are used to describe the
disease-specific, abnormal accumulations of PrP that are charac-
teristically found only in prion-affected tissues and considered a
reliable biochemical marker for the presence of infectious prions
[10]. Disease-specific PrP (PrPd) accumulations are relatively
resistant to proteinase K (PK) digestion, whereas cellular PrPC is
destroyed. Where we were able to confirm this resistance by
treatment of samples with PK and subsequent paraffin-embedded
tissue (PET) immunoblot analysis [34], PrPSc is used as a
biochemical marker for the presence of prions. Unfortunately,
treatment of tissue sections with PK destroys the microarchitec-
ture. Therefore, for IHC analysis tissue sections were fixed and
pre-treated to enhance the detection of the disease-specific
abnormal accumulations of PrP (PrPd), whereas cellular PrPC is
denatured by these treatments [4]. We have repeatedly shown in a
series of studies that these PrPd-accumulations occur only in prion-
infected tissues, and correlate closely with the presence of ME7
scrapie prions [1,4,13,35–37].
Within weeks after i.p. exposure of WT mice to ME7 scrapie
prions, strong accumulations of prion-specific PrPSc occur upon
FDCs within the spleen and are sustained until the terminal stages
of disease [1,13,35]. Here, mice were injected i.p. with ME7
scrapie prions and spleens from 4 mice from each group collected
35, 70 and 105 days after exposure. In spleens from control mice
(Prnp+/-RPrnp+/- mice) heavy PrPd accumulations, consistent with
localisation upon FDC, were detected at 70 days after i.p. injection
with the scrapie agent and had increased in intensity by 105 days
after infection (Figure 4A & B). PET immunoblot confirmed the
presence of PrPSc upon the surfaces of the FDC in spleens from
control mice (Figure 4C). Furthermore, in the spleens of
Prnpstop/-RCD21-Cre Prnpstop/- mice in which cellular PrPC was
expressed only on FDC, heavy PrPSc accumulations were likewise
maintained upon FDC (Figure 4A & B). In contrast, in the absence
of PrPC expression by FDC in the spleens of CD21-Cre
Prnpstop/-RPrnpstop/- mice, no PrPSc accumulations were observed
upon FDC. In the spleens of mice with PrPC-deficient FDC, if PrP
was detected at all, it was only occasionally observed within
tingible body macrophages (Figure 4A and B, arrowheads; Figure
S1). We also analysed prion infectivity levels in spleens collected 70
days after infection from control mice (Prnp+/-RPrnp+/- mice) and
Prnpstop/-RCD21-Cre Prnpstop/- mice in which cellular PrPC was
expressed only on FDC (Figure S2; n= 3/group). As anticipated
high levels of prion infectivity were observed in each control
from blood (lower panel). B, blood; S, spleen; T, tail; M, DNA size markers; a, b, c, control DNA samples for each transgene combination tested which
were (a) Prnp-/-, (b) Prnpstop/- and (c) complete recombination of the stop cassette within the Prnpstop/- allele. C) IHC analysis of PrPC expression (blue)
by FDC (CD35+ cells; red) and sympathetic nerves (TH+ cells, green) confirmed PrPC expression was restricted to FDC in spleens of Prnpstop/-RCD21-
Cre Prnpstop/- mice. Scale bar, 100 mm. D) Morphometric analysis confirmed that the magnitude of the PrPC expression co-localized upon the surfaces
of FDC in the spleens of Prnpstop/-RCD21-Cre Prnpstop/- mice was similar to that observed upon FDC in spleens from Prnp+/-RPrnp+/- control mice
(p,0.690, n=48 FDC networks/group). In contrast, in the absence of Cre-recombinase expression by FDC in CD21-Cre Prnpstop/-RPrnpstop/- mice, PrPC
expression was substantially lower than that observed upon FDC in spleens from Prnp+/-RPrnp+/- control mice (p,1610-25, n=48 FDC networks/
group). E) Morphometric analysis confirmed that PrPC expression upon the surfaces of sympathetic nerves in the spleens of Prnpstop/-RCD21-Cre
Prnpstop/-, CD21-Cre Prnpstop/-R CD21-Cre Prnpstop/- and CD21-Cre Prnpstop/-RPrnpstop/- mice was significantly ablated when compared to that
observed upon sympathetic nerves in spleens from Prnp+/-RPrnp+/- control mice (p,1610-25, n= 48 sympathetic nerves/group). For all panels n=6
mice/group.
doi:10.1371/journal.ppat.1002402.g002
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spleen. Furthermore, consistent with data above our analysis
showed that PrPc expression only of FDC was sufficient to sustain
high levels of prion infectivity within the spleen (Figure S2). These
data demonstrate that PrPC expression only on FDC is sufficient to
sustain prion replication in the spleen. In the absence of PrPC
expression on FDC the prions appeared to be scavenged by
tingible body macrophages resident within the B cell follicles.
FDC-specific Prnp-ablation
Next, mice were created in which Prnp expression was
specifically ablated in FDC. To do so, CD21-Cre Prnp-/- mice
were crossed with mice carrying a ‘‘floxed’’ Prnp gene (Prnpflox/flox
mice; [31]). In the progeny CD21-Cre Prnpflox/- mice, Prnp
expression is conditionally ablated in cells expressing Cre
recombinase (CD21-expressing FDC and mature B cells). To
restrict the Prnp-ablation to FDC, CD21-Cre Prnpflox/- mice were
lethally c-irradiated and grafted with bone marrow from Cre-
deficient Prnpflox/- mice (Prnpflox/-RCD21-Cre Prnpflox/- mice). We
also performed bone marrow transfers from CD21-Cre Prnpflox/-
donors into CD21-Cre Prnpflox/- recipients (CD21-Cre Prnpflox/-
miceRCD21-Cre Prnpflox/- mice), CD21-Cre Prnpflox/- donors into
Cre-deficient Prnpflox/- mice (CD21-Cre Prnpflox/-RPrnpflox/- mice),
and Prnp+/- donors into Prnp+/- recipients (Prnp+/-RPrnp+/- mice) as
controls (Figure 5A). Spleens, tails and blood from 6 mice from
each group were examined 100 days after bone marrow
transfusion. PCR analysis of DNA isolated from the spleens,
blood and tails of Prnpflox/-RCD21-Cre Prnpflox/- mice confirmed
that efficient Cre-mediated DNA recombination and Prnp-ablation
was restricted to the FDC-containing stromal compartment of the
spleen (Figure 5B). In Prnpflox/-RCD21-Cre Prnpflox/- mice the
recombined Prnpstop/- allele (Prnpdeflox) was detected in the spleen,
but not blood and tail. Thus these data indicate that in the spleens
of Prnpstop/-RCD21-Cre Prnpstop/- mice Cre-mediated recombi-
nation and Prnp-ablation is restricted to FDC and not B cells.
IHC analysis showed that in the spleens of Prnpflox/-RCD21-
Cre Prnpflox/- mice and CD21-Cre Prnpflox/- miceRCD21-Cre
Prnpflox/- mice FDC did not express PrPC whereas high levels were
associated with TH-positive sympathetic nerves (Figure 5C). In the
absence of Cre-recombinase expression by FDC in CD21-Cre
Prnpflox/-RPrnpflox/- mice, high levels of PrPC were expressed by
FDC and sympathetic nerves (Figure 5C).
Morphometric analysis confirmed that the magnitude of the
PrPC expression co-localized upon the surfaces of FDC in the
spleens of Prnpflox/-RCD21-Cre Prnpflox/- mice and CD21-Cre
Prnpflox/- miceRCD21-Cre Prnpflox/- mice was substantially lower
than that observed upon FDC in spleens from Prnp+/-RPrnp+/-
control mice (P,1610-24 and P,1610223, respectively, n= 48
FDC/group) and not significantly different when compared to
background levels (Figure 5D). In contrast, in the absence of Cre-
recombinase expression by FDC in CD21-Cre Prnpflox/-RPrnpflox/-
mice, PrPC expression was not significantly different from the level
observed upon FDC in spleens from Prnp+/-RPrnp+/- control mice
(P,0.106; Figure 5D). In contrast, morphometric analysis showed
that the magnitude of the PrPC expression co-localized upon the
surfaces sympathetic nerves in the spleens of Prnpflox/-RCD21-Cre
Prnpflox/-, CD21-Cre Prnpflox/-R CD21-Cre Prnpflox/- and CD21-
Cre Prnpflox/-RPrnpflox/- mice was similar to that observed upon
sympathetic nerves in spleens from Prnp+/-RPrnp+/- control mice
(p= 0.400, n= 48 sympathetic nerves/group). Together, these data
confirm that in the spleens of Prnpflox/-RCD21-Cre Prnpflox/- mice
the Prnp ablation is specifically restricted to FDC.
Effect of FDC-specific Prnp-ablation on FDC status and
splenic microarchitecture
Data in the current study definitively demonstrate that FDC
express high levels of PrPC but the role PrPC plays in FDC
function and homeostasis is not known. IHC analysis showed that
the microarchitecture of the FDC networks from Prnp-ablated
Prnpflox/-RCD21-Cre Prnpflox/- mice were normal when compared
to control mice (Figure 6A). Furthermore, no significant difference
was observed in the size (P= 0.750, n= 32) and number (P= 0.713,
n= 32 of the FDC networks in spleens from each mouse group
(Figure 6B & C, respectively). The relative positioning of the FDC
and sympathetic nerves was likewise similar in spleens from each
mouse group (Figure 6D & E; P,0.765, n= 48).
FDC characteristically trap and retain native antigen on their
surfaces in the form of immune complexes, consisting of antigen-
antibody and/or complement components. Antigens trapped on
the surface of FDC are considered to promote immunoglobulin-
isotype class switching, affinity maturation of naı¨ve IgM+ B cells
and the maintenance of immunological memory [38–42]. Indeed,
prions are also considered to be acquired by FDC as complement-
opsonized immune complexes [15–18]. To determine whether
antigen retention by Prnp-ablated FDC was affected six mice from
each group were passively immunized with preformed PAP
immune complexes, and 24 h later, the presence of FDC-
associated immune complexes identified by IHC (Figure 7) and
the presence of peroxidase activity (data not shown). No significant
difference in the magnitude of immune complex trapping could be
detected between FDC from Prnp-ablated Prnpflox/-RCD21-Cre
Prnpflox/- mice and control mice (Figure 7; P= 0.85, n= 40/group).
Together, these data demonstrate that Prnp-ablation does not
impair FDC status or their ability to trap and retain immune
complexes.
FDC-restricted PrPC-ablation blocks prion replication in
the spleen
Next, the effect of FDC-specific Prnp-ablation on prion
replication by FDC was determined. Mice were injected i.p. with
ME7 scrapie prions and spleens from 4 mice from each group
collected 70 days after exposure. As anticipated, heavy PrPd
(Figure 8A and B) and PrPSc (Figure 8C) accumulations consistent
with localisation upon FDC were detected in spleens from control
mice (Prnp+/-RPrnp+/- mice) and mice in which Prnp was ablated
only in mature B cells (CD21-Cre Prnpflox/-RPrnpflox/- mice). In
the spleens in which cellular PrPC was ablated only on FDC
(Prnpflox/-RCD21-Cre Prnpflox/- mice), or FDC and mature B cells
(CD21-Cre Prnpflox/-RCD21-Cre Prnpflox/- mice), no PrP accu-
mulations were observed upon FDC (Figure 8A–C). Consistent
Figure 3. Effect of FDC-restricted PrPc expression on the spleens of Prnpstop/-RCD21-Cre Prnpstop/- mice. A) IHC analysis of the status of
FDC networks (C4-binding cells and CD21/CD35+ cells; red), B cells expressing CD45R (red), and CD3+ T cells (green). Morphometric analysis confirmed
that there were no significant difference in the size (B) and number (C) of the CD35+ FDC networks in spleens from Prnpstop/-RCD21-Cre Prnpstop/-,
CD21-Cre Prnpstop/-RCD21-Cre Prnpstop/-, CD21-Cre Prnpstop/-RPrnpstop/- mice and Prnp+/-RPrnp+/- control mice (n= 32 FDC networks/group). D and
E), Comparison of the sympathetic innervation in spleens from each mouse group. D) IHC detection of TH-positive sympathetic nerves (green) and
FDCs (CD35+ cells; red). Scale bar, 50 mm. E) Quantitative analysis of the relative positioning of the FDC and sympathetic nerves showed there were no
significant differences in average distance between these cell populations in spleens from each mouse group (P=0.932, n= 48 FDC networks/group).
For all panels n= 6 mice/group.
doi:10.1371/journal.ppat.1002402.g003
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with data above (Figure 4), in spleens of mice with PrPC-deficient
FDC PrP accumulations were only occasionally observed within
tingible body macrophages (Figure 8A and B, arrowheads; Figure
S1). We also analysed prion infectivity levels in spleens from
Prnpflox/-RCD21-Cre Prnpflox/- mice in which cellular PrPC
expression was ablated only on FDC (Figure S2; n= 3). Consistent
with data above this analysis showed that in the absence of PrPc
expression only on FDC the accumulation of high levels of prion
infectivity in the spleen was blocked (Figure S2). Taken together,
these data show that in the specific absence of PrPC expression
FDC are unable to sustain prion replication upon their surfaces
and as a consequence the agent is scavenged by tingible body
macrophages.
FDC-restricted PrPC-ablation does not influence prion
disease and susceptibility when infection is established
directly within the CNS
When mice with PrPC-ablated FDC (Prnpflox/-RCD21-Cre
Prnpflox/- mice) were injected intracerebrally (i.c.) with the ME7
scrapie agent strain directly into the CNS all mice succumbed to
clinical signs of scrapie approximately 300 days after exposure
with incubation periods indistinguishable from those of Prnp+/-
control mice [43] (Prnpflox/-RCD21-Cre Prnpflox/-, 29764 days,
n= 4; Prnp+/-, 29064 days, n= 5; P= 0.386). Histopathological
analysis showed that brains from all clinically-affected mice from
each group displayed the characteristic spongiform pathology,
astrogliosis, microgliosis and PrPd accumulation typically associ-
ated with terminal infection with the ME7 scrapie agent
(Figure 9A). Following i.c.-injection with the ME7 scrapie agent,
high levels of PrPSc accumulate upon FDC and are maintained for
the duration of the incubation period [13](Figure 9B and C).
However, FDC are not critical for ME7 scrapie pathogenesis when
infection is established directly within the CNS [4,13,35,44]. In the
spleens from clinically-scrapie affected mice in which PrPC
expression was specifically ablated only on FDC
(Prnpflox/-RCD21-Cre Prnpflox/- mice), PrPSc replication upon
FDC was also blocked. These data how that FDC do not simply
trap and retain prions after their release from infected neurones in
the CNS. These data also confirm that the Prnp-ablation in
Prnpflox/-RCD21-Cre Prnpflox/- mice was specific to FDC and had
no effect on prion neuropathogenesis and disease susceptibility
when the infection was established directly in the CNS.
Effect of FDC-restricted PrPC-ablation prion
neuroinvasion after i.p. exposure
Studies in mice show that efficient prion neuroinvasion from
peripheral sites of exposure is dependent upon the presence of
FDC in lymphoid tissues [1,4,35,44–46]. Next, the effect of FDC-
specific Prnp-ablation on prion neuroinvasion via the peritoneal
route was determined. Unfortunately, due to the advanced ages of
the mice in this experiment, some succumbed to ageing-related
inter-current illness. As there was a 100 days interval between the
time of lethal c-irradiation/bone marrow reconstitution and prion
infection, many mice were approximately 500–600 days old when
culled. However, most mice with PrPC-expressing FDC in their
spleens succumbed to clinical prion disease after i.p. injection
(Prnp+/-R Prnp+/- control mice, n= 5/7; CD21-Cre Prnpflox/-
RPrnpflox/- mice, n= 3/6; Table S1). Histopathological analysis
showed that brains from all clinically-affected mice from these
groups displayed the characteristic spongiform pathology, astro-
gliosis, microgliosis and PrPd accumulation typically associated
with terminal infection with the ME7 scrapie agent (Figure S3,
third and fourth columns). In contrast, none of the mice with
PrPC-ablated FDC (Prnpflox/-RCD21-Cre Prnpflox/- mice, n= 0/6;
CD21-Cre Prnpflox/-RCD21-Cre Prnpflox/- mice, n= 0/7) suc-
cumbed to clinical prion disease during their life-spans (Table S1).
Although we cannot exclude the possibility that if the clinically-
negative mice with PrPC-ablated FDC mice had lived longer some
may have succumbed to clinical prion disease after substantially
extended incubation periods, no PrPd or other characteristic
histopathological hallmarks of prion disease were detected in their
brains (Figure S3, first two columns). Together, these data suggest
that in the specific absence of PrPC expression on FDC
neuroinvasion following peripheral exposure is impaired.
Discussion
These data definitively demonstrate that FDC are essential sites
of prion replication in lymphoid tissues. In order to precisely
establish the role of FDC in prion pathogenesis two unique
compound transgenic mouse models were created in which PrPC
expression was specifically ‘‘switched on’’ or ‘‘off’’ only on FDC.
Our data confirm that FDC express high levels of PrPC and do not
simply acquire it from other host cells. Furthermore, we show that
following peripheral exposure PrPC-expressing FDC alone are
sufficient to sustain high levels of prion replication in the spleen.
Accordingly, when PrPC-expression was specifically ablated only
on FDC prion replication in the spleen was blocked. These data
likewise demonstrate that FDC do not simply acquire prions after
their release from other infected host cells. Our analysis showed
that the effects of Prnp-ablation on prion replication in the spleen
were specific to FDC and had no effect on prion neuropathogen-
esis when the infection was established directly in the CNS. In the
absence of PrPC expression on FDC the PrPSc from the initial
inoculum appeared to be scavenged by tingible body macrophages
resident within the B cell follicles. Together, these data definitively
demonstrate that FDC are the critical early sites of prion
replication in lymphoid tissues. This study is the first to
demonstrate that the specific ablation of a cellular protein only
on FDC, without apparent consequences for FDC status and
function, blocks the replication of an important pathogen in the
spleen.
FDC reside in the primary B cell follicles and germinal centres
of lymphoid tissues and are a completely distinct cell lineage from
bone-marrow-derived classical dendritic cells [47–49]. FDC
possess many slender and convoluted dendritic processes which
provide the FDC with an extremely large surface area. This helps
the FDC to efficiently trap and retain large amounts of native
antigen in the form of immune complexes, consisting of antigen-
Figure 4. Effect of FDC-restricted PrPc expression on PrPSc accumulation in the spleen. Mice were injected i.p. with the ME7 scrapie agent
and tissues collected 35, 70 days and 105 days after exposure. A and B) High levels of PrPd were detected in association with FDC (CD21/35 positive
cells) in the B cell follicles (CD45R positive cells) of spleens of mice with PrPC-expressing FDC: Prnpstop/-RCD21-Cre Prnpstop/- mice, CD21-Cre
Prnpstop/-RCD21-Cre Prnpstop/- mice and Prnp+/-RPrnp+/- control mice. B) High magnification images of the sites of PrPd accumulation (red) at 70 days
post-injection with scrapie. Arrowheads show PrP-accumulation within tingible body macrophages. C) Analysis of adjacent sections by PET-
immunoblot analysis confirmed the presence of PK-resistant PrPSc (blue/black). In contrast, no PrPd or PrPSc was detected in spleens of CD21-
CreRPrnpstop/-mice that lacked PrPC-expressing FDC. Arrows indicate PrPSc accumulation upon FDC. A, scale bar = 100 mm. B, scale bar = 20 mm. C,
scale bar = 500 mm. For all panels n= 4 mice/group.
doi:10.1371/journal.ppat.1002402.g004
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Figure 5. FDC-restricted PrPc-ablation in the spleens of Prnpflox/-RCD21-Cre Prnpflox/- mice. A) The anticipated distribution of PrPC
expression on FDC and B cells in tissues from each mouse group. B) PCR analysis of DNA isolated from the spleens, blood and tails of
Prnpflox/-RCD21-Cre Prnpflox/- mice confirmed that efficient Cre-mediated DNA recombination and Prnp-ablation (Prnpdeflox) was restricted to the
FDC-containing stromal compartment of the spleen. Cre-mediated recombination of CD21-expressing lymphocytes was efficiently prevented in these
mice by the irradiation and transfer of Prnpflox/- bone marrow as demonstrated by the lack of a Prnpdeflox band in DNA extracted from blood (lower
panel). B, blood; S, spleen; T, tail; M, DNA size markers; a, b, c, d control DNA samples for each transgene combination tested which were (a) Prnpflox/flox,
(b) Prnpflox/-, (c) Prnp-/- and (d) Prnpflox/- with complete recombination of the floxed exon 3. C) IHC analysis of PrPC expression (blue) by FDC (CD35+ cells;
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antibody and/or complement components. The longevity of FDC
ensures that antigen is retained upon their surfaces for long periods
[50,51]. Antigens trapped on the surface of FDC are considered to
promote immunoglobulin-isotype class switching, affinity matura-
tion of naı¨ve IgM+ B cells and the maintenance of immunological
memory [38–42]. FDC are also considered to aid the clearance of
apoptotic B lymphocytes [52], and play a role in infection with
human immunodeficiency virus [53] and the pathogenesis of
chronic inflammatory and autoimmune diseases [54] and
peripherally-acquired prion infections.
A number of studies have addressed the role of FDC in prion
pathogenesis. They show that prion replication in the spleen and
subsequent neuroinvasion are both impaired in immunodeficient
mice that lack FDC [4,44,45], or following their temporary de-
differentiation [1,35,46]. Although the precise identity of FDC
precursor cells is unknown, other studies have exploited their non-
haematopoietic-origin to address their role in prion pathogenesis.
In these bone marrow chimera studies, mismatches were created
in Prnp expression between the FDC-containing stromal and
haematopoietic compartments by grafting bone marrow cells from
PrP-deficient (Prnp-/-) mice into PrP-expressing wild-type mice,
and vice versa [13,14]. Using this approach FDC and all other
stromal cells were derived from the recipient, whereas lymphocytes
and other haematopoietic lineages were derived from the donor
cells. Following peripheral exposure prion accumulation upon
FDC was only detected in the spleens of mice with a Prnp-
expressing stromal compartment.
While the above studies clearly show that the presence of FDC
is important for prion replication in the spleen, it was not possible
to dissociate the Prnp expression status of FDC from that of the
nervous system and all other non-haematopoietic host-cell
populations and therefore precisely characterise the role of FDC
in prion neuroinvasion [13,14]. This is important for a number of
reasons. Firstly, prion infection can occur within inflammatory
PrPC-expressing stromal cells that are distinct from FDC [23].
Secondly, the FDC’s ability to bind exosomes may have lead to the
wrong interpretation to be made in earlier studies describing their
ontology [55]. Most evidence indicates that FDC do not derive
from haematopoietic precursors [29,49]. However, the detection
of donor bone marrow derived MHC class-I molecules, and other
donor-derived antigens, on the surface of FDC in recipient mice
was considered evidence of FDC precursor cells within bone
marrow [55]. With hindsight these observations are most likely
due to the FDC’s capacity to acquire exosome-associated antigens
from other cell types [21]. Both PrPC and PrPSc can be released
from cells in association with exosomes [20]. The possibility,
therefore, cannot be excluded that FDC passively acquire prions
after their release in exosomes from other infected non-
haematopoietic cell populations. Finally, FDC characteristically
trap and retain immune complexes on their surfaces. FDC express
negligible levels of complement component C4 at the mRNA level
but the detection of abundant activated C4 on their surfaces by
IHC using mAb FDC-M2 (as used in this study) is indicative of the
capture and retention of immune complexes by FDC [32].
Opsonising complement components and cellular CR are likewise
considered to play an important role in the retention of prions by
FDC [15,16,18]. Thus FDC may simply act as concentrating
depots for prion-containing complement-opsonized immune
complexes.
The practical hurdles that are encountered when attempting to
isolate highly purified FDC from lymphoid tissues have made
detailed analysis of their pathobiological functions extremely
difficult. The main issues include: contamination with other cell
types such as B cells and tingible body macrophages which express
MFGE8 (FDC-M1), a common marker used to identify FDC
[52,56], low yield, and their dependence on constitutive
lymphotoxin b receptor-stimulation to maintain their differentiat-
ed state [57]. FDC and mature B cells express high levels of Cr2
which encodes the complement receptors CR2/CR1 (CD21/35)
[18,27]. A previous study used CD21-cre mice to study FDC-
specific gene function [27]. In the current study, our data confirm
that Cre/loxP-mediated DNA recombination was specific to FDC
and mature B cells in CD21-cre mice, and could be restricted to
FDC by transfusing the mice with Cre-deficient bone marrow. In
some Cre transgenic mouse lines Cre-toxicity is encountered
whereby Cre recombinase causes mis-recombination, DNA
damage and death of Cre-expressing cells [30]. However, our
analysis suggested no significant effect of Cre-expression on the
number, size and status of FDC networks and B cell follicles.
CD21-Cre mice are therefore a powerful in vivo tool in which to
study FDC-specific gene expression and function.
Expression of PrPC is mandatory for host cells to sustain prion
infection [43]. In the current study to establish whether FDC
actively amplify prions a compound transgenic mouse model was
created using the CD21-cre mouse line to specifically ‘‘switch on’’
PrPC expression only on FDC (Prnpstop/-RCD21-Cre Prnpstop/-
mice). As a consequence, only FDC in these mice had the potential
to be actively infected with and replicate prions. Our analysis
showed that expression of PrPC only on FDC was sufficient to
sustain high levels of PrPSc accumulation upon FDC in the spleen
after peripheral prion exposure. These data definitively demon-
strate that FDC are the critical sites of prion replication in
lymphoid tissues. Ultrastructural analysis of the cellular compart-
ments within which PrPd localizes upon/within FDC has failed to
show any intracellular accumulation. Instead the PrPd appears to
be restricted to the plasmalemma of their dendritic processes [58].
This implies that early de novo PrPSc conversion occurs upon the
surface of FDC.
A second compound transgenic mouse model was created in
which PrPC expression was specifically ‘‘switched off’’ only on
FDC (Prnpflox/-RCD21-Cre Prnpflox/- mice). If, as shown above,
FDC do actively amplify prions, then one would also expect the
specific ablation of PrPC expression only on FDC to block prion
replication in the spleen. Our data confirmed this to be the case.
As PrPC expression in all other host cells (eg: neurones) in these
mice was unaffected, these data clearly show that FDC do not
simply acquire prions following release from other infected host
cells, even in mice with clinical prion disease in the brain. IHC
red) and sympathetic nerves (TH+ cells, green) confirmed the PrPC-ablation was restricted to FDC in spleens of Prnpflox/-RCD21-Cre Prnpflox/- mice. Scale
bar, 100 mm. D) Morphometric analysis confirmed that the magnitude of the PrPC expression co-localized upon the surfaces of FDC in the spleens of
Prnpflox/-RCD21-Cre Prnpflox/- mice was significantly lower than that observed upon FDC from Prnp+/-RPrnp+/- control mice (P,1.0610-24, n=48 FDC
networks/group). In contrast, in the absence of Cre-recombinase expression by FDC in CD21-Cre Prnpflox/-RPrnpflox/-mice, PrPC expression was similar to
that observed upon FDC in spleens from Prnp+/-RPrnp+/- control mice (P=0.106, n=48 FDC networks/group). E) Morphometric analysis confirmed that
the magnitude of the PrPC expression co-localized upon the surfaces sympathetic nerves in the spleens of Prnpflox/-RCD21-Cre Prnpflox/-, CD21-Cre
Prnpflox/-R CD21-Cre Prnpflox/- and CD21-Cre Prnpflox/-RPrnpflox/- mice was not significantly different when compared to that observed upon
sympathetic nerves in spleens from Prnp+/-RPrnp+/- control mice (p=0.400, n=48 sympathetic nerves/group). For all panels n=6 mice/group.
doi:10.1371/journal.ppat.1002402.g005
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analysis implied that in the spleens of mice with PrP-deficient FDC
the prions appeared to be scavenged by tingible body macro-
phages resident within the B cell follicles. The lack of detection of
PrPd within tingible body macrophages in the spleens of clinically-
affected mice with PrP-deficient FDC (Figure 9) clearly demon-
strates that these cells are not alternative sites of replication of
ME7 scrapie prions. High levels of prions rapidly accumulate
within the spleen and other lymphoid tissues within weeks of
peripheral exposure. The magnitude of the prion accumulation
within the spleen rapidly reaches a plateau level which is
maintained for the duration of the disease [13,44]. The
maintenance of this plateau may be the consequence of a
competitive state whereby FDC act to amplify prions above the
threshold required to achieve neuroinvasion, whereas phagocytic
cells such as macrophages act to destroy them [59,60]. Indeed
increased numbers of PrPd-containing tingible body macrophages
are found within the B cell follicles of TSE-affected animals [58].
Thus, our data suggest that in the specific absence of PrPC
expression by FDC the initial inoculum is phagocytosed and
gradually degraded by mononuclear phagocytes such as tingible
body macrophages [59,60]. These data are congruent with data
from our earlier study which likewise occasionally detected trace
levels of prions from the initial inoculum within tingible body
macrophages in the spleens of mice with a PrPC-deficient FDC-
containing stromal compartment [13].
The density of sympathetic nerves can significantly influence the
amount of prion accumulation in the spleen [33]. In the current
study the distribution of TH-positive sympathetic nerves in the
spleens of the FDC-specific gene targeted mouse lines was not
adversely affected. Furthermore, when prions were injected
directly to the brain, FDC-specific Prnp ablation had no influence
on the onset of clinical disease or the neuropathology. These data
provide strong evidence that the effects of Cre-mediated Prnp
ablation on prion replication in the spleen were specific to FDC
and not due to unregulated ablation of PrPC expression within the
nervous system. In the current study PrPSc accumulation upon
PrPC-ablated FDC (Prnpflox/-RCD21-Cre Prnpflox/- mice) was
blocked even in spleens from i.c. injected clinically-scrapie affected
mice. These data contrast those reported by Crozet and colleagues
[61] which used Tg(OvPrP4) mice that express the ovine PRNP
gene under the control of the neuron-specific enolase promoter on
a murine Prnp-/- background. As a consequence ovine PrPC is
expressed only in neurones. In contrast to data in the current
study, when Tg(OvPrP4) mice were injected i.c. with a high dose
of natural sheep scrapie PrPSc was detected in the germinal centres
of their spleens. The reasons for this discrepancy are uncertain.
However, the expression of PrPC in the neuronal compartment of
Tg(OvPrP4) mice is 2-4X higher than in controls. In the current
study in mice in which PrPC was ablated only on FDC
(Prnpflox/-RCD21-Cre Prnpflox/- mice) the expression of murine
Prnp in Cre-deficient cells such as neurones is controlled by the
endogenous Prnp promoter and expressed at similar levels to
controls (Figure 5E). In the presence of increased PrPC expression
on neurones it is plausible that greater prion replication occurred
within the peripheral nervous system, which may have been
subsequently trapped on the surface of the FDC and scavenged by
macrophages as the prion burden increased. Similarly, hyper-
innervation of the spleen likewise leads to increase prion burden in
this tissue [33].
In conclusion, our data demonstrate that PrPC-expressing FDC
are the essential sites of prion replication in lymphoid tissues.
Indeed, PrPC-expression on FDC alone was sufficient to sustain
high levels of prion replication. In contrast, the specific ablation of
PrPC expression on FDC blocked prion replication. Although
FDC have the capacity to bind exosomes and immune complexes
which may contain PrPSc, this finding clearly demonstrates that
FDC do not simply passively acquire prions from other infected
cell populations such as neurones. Previous data show treatments
which impair the status or immune complex-trapping function of
FDC reduce prion susceptibility after peripheral exposure
[1,16,35,46,62]. The demonstration that Prnp-ablation only on
FDC blocked splenic prion replication without apparent conse-
quences for FDC status represents a novel opportunity to prevent
neuroinvasion by modulation of PrPC expression on FDC.
Materials and Methods
Ethics statement
All studies using experimental mice and regulatory licences were
approved by both The Roslin Institute’s and University of
Edinburgh’s Protocols and Ethics Committees. All animal
experiments were carried out under the authority of a UK Home
Office Project Licence within the terms and conditions of the strict
regulations of the UK Home Office ‘Animals (scientific proce-
dures) Act 1986’. Where necessary, anaesthesia appropriate for the
procedure was administered, and all efforts were made to
minimize harm and suffering. Mice were humanely culled using
by a UK Home Office Schedule One method.
Mice
The CD21-Cre [26], ROSA26flox/flox reporter strain [28],
Prnp-/- [12] mice and tga20 mice over-expressing PrPc [63] were
generated as described previously. Prnpflox/flox mice have loxP sites
flanking exon 3 of the Prnp gene [31]. Prnpstop/- mice have a floxed
b-geo cassette inserted into intron 2 of the Prnp gene upstream of
exon 3 [31]. Mice were maintained under SPF conditions.
Genotype confirmation by PCR analysis
Prior to their use in experiments, the genotype of each mouse
was confirmed by PCR analysis. DNA was prepared from tails,
blood and spleens using the DNeasy blood and tissue kit (Qiagen,
Crawley, UK) according to the manufacturer’s instructions.
Where indicated DNA samples were analysed for presence of
Cre, LacZ, Prnp+/+, Prnp-/-, Prnpflox, recombined Prnpflox (Prnpde-flox),
Prnpstop and recombined Prnpstop (Prnpstop(R)) using the primers
listed in Table 1. PCR products were resolved by electrophoresis
through a 1.0% agarose gel containing 0.002% GelRed (Biotium,
Cambridge Biosciences Ltd, Cambridge, UK).
Figure 6. Effect of FDC-restricted PrPC-ablation on FDC status. A) IHC analysis of the status of FDC (C4-binding cells and CD21/CD35+ cells;
red), B cells expressing CD45R (red), and CD3+ T cells (green). Morphometric analysis confirmed that there were was no significant difference in the
size (B) and number (C) of the CD35+ FDC networks in spleens of mice from each mouse group (n= 32 FDC networks/group). D and E), Comparison of
the sympathetic innervation in spleens from Prnpflox/-RCD21-Cre Prnpflox/-, CD21-Cre Prnpflox/-RCD21-Cre Prnpflox/-, CD21-Cre Prnpflox/-R
Prnpflox/-mice and Prnp+/-RPrnp+/- control mice. D) IHC detection of TH-positive sympathetic nerves (green) and FDCs (CD35+ cells; red). Scale
bar, 50 mm. E) Quantitative analysis of the relative positioning of the FDC networks and sympathetic nerves showed there was no significant
difference in the average distance between these cell populations in spleens from each mouse group (P= 0.765, n= 48 FDC networks/group). For all
panels n=6 mice/group.
doi:10.1371/journal.ppat.1002402.g006
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Figure 7. Effect of FDC-restricted PrPC-ablation on immune complex trapping. A) Mice were passively immunized with preformed PAP
immune complexes, and 24 h later, the presence of immune complexes (red) upon FDC (CD35+ cells, green) assessed by IHC. Scale bar, 100 mm. B)
Morphometric analysis confirmed that the magnitude of the immune complex-trapping co-localized upon the surfaces of FDC from Prnp-ablated
Prnpflox/-RCD21-Cre Prnpflox/- mice was not significantly different from that observed in spleens from control mice. This analysis also confirmed that
the immune complexes were preferentially associated with FDC in these tissues and significantly greater than the null hypothesis that the pixels were
randomly distributed. *, P,1610221; **, P,1610232; *** P,9610228; n= 40 FDC networks/group. For all panels n= 6 mice/group.
doi:10.1371/journal.ppat.1002402.g007
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c-Irradiation and bone-marrow reconstitution
Bone-marrow from the femurs and tibias of donor mice was
prepared as single-cell suspensions (36107–46107 viable cells/ml)
in HBSS (Invitrogen, Paisley, UK). Recipient adult (6–8 weeks old)
mice were c-irradiated (950 rad) and 24 h later reconstituted with
100 ml bone-marrow by injection into the tail vein. Recipient mice
were used in subsequent experiments as described 100 days after
bone marrow reconstitution to allow sufficient time for removal of
Figure 8. Effect of FDC-restricted PrPC-ablation on PrPSc accumulation in the spleen. Mice were injected i.p. with the ME7 scrapie agent
and tissues collected 70 days after exposure. A) High levels of PrPd (red, left-hand column) were detected in association with FDC (red, middle
column) in the B cell follicles (red, right-hand column) of spleens from CD21-Cre Prnpflox/-RPrnpflox/-mice and Prnp+/-RPrnp+/- control mice that
contained PrPC-expressing FDC. B) High magnification images of the sites of PrPd accumulation (red) at 70 days post-injection with scrapie. C) PET
blot analysis of analysis of adjacent sections by PET-immunoblot analysis confirmed presence of PK-resistant PrPSc (blue/black). In contrast, no PrPSc
was detected in spleens of Prnpflox/-RCD21-Cre Prnpflox/- and CD21-Cre Prnpflox/-RCD21-Cre Prnpflox/- mice that lacked PrPC-expressing FDC. In the
spleens of some of these mice, low levels of PrPd were occasionally localised within tingible body macrophages (B, arrowheads). A, scale bar
= 100 mm. B, scale bar = 20 mm. C, scale bar = 500 mm. Arrows indicate PrPSc accumulation upon FDC. For all panels n= 4 mice/group.
doi:10.1371/journal.ppat.1002402.g008
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Figure 9. Effect of FDC-restricted PrPC-ablation on PrPSc accumulation in the brains and spleens of scrapie-affected mice. Control
mice (Prnp+/- mice) and Prnpflox/-RCD21-Cre Prnpflox/- mice that lacked PrPC-expressing FDC were injected i.c. with the scrapie agent directly into the
CNS. Brains and spleens were collected from clinically scrapie-affected mice to compare the neuropathology and cellular sites of PrPSc accumulation.
A) High levels of spongiform pathology (H&E, upper row), heavy accumulations of PrPd (brown, second row), reactive astrocytes expressing GFAP
(brown, third row) and active microglia expressing Iba-1 (brown, bottom row) were detected in the hippocampi of the brains of all clinically scrapie-
affected mice. Scale bars, 500 mm. B) High levels of PrPd (red) were detected in association with FDC in spleens from clinically scrapie-affected control
mice that contained PrPC-expressing FDC. C) PET blot analysis of analysis of adjacent sections by PET-immunoblot analysis confirmed the presence of
PK-resistant PrPSc (blue/black). In contrast, no PrPd or PrPSc was detected in spleens of Prnpflox/-RCD21-Cre Prnpflox/- that lacked PrPC-expressing FDC.
Scale bars = 500 mm.
doi:10.1371/journal.ppat.1002402.g009
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long-lived B lymphocyte populations and their replacement from
the donor bone marrow.
Histological assessment of Lacz expression
Tissues were first immersed in LacZ fixative [PBS (pH 7.4)
containing 2% paraformaldehyde, 0.2% gluteraldehyde, 0.02%
Nonidet P40, 0.01% sodium deoxycholate, 5 mM EGTA, 2 mM
MgCl2] and washed in LacZ wash buffer [PBS (pH 7.4) containing
0.02% Nonidet P40, 0.01% sodium deoxycholate, 2 mM
MgCL2]. Tissues were subsequently incubated in 15% (wt/vol)
sucrose in PBS overnight followed by a further overnight
incubation in 30% (wt/vol) sucrose in PBS and embedded in
Tissue-Tek O.C.T. compound (Bayer PLC, Newbury, UK). Serial
sections (thickness 8 mm) were cut on cryostat and stained
overnight at 37uC with LacZ staining solution (Glycosynth,
Warrington, UK). Staining reaction was stopped by washing in
LacZ wash buffer followed by dH2O. Sections were counterstained
with nuclear fast red (Vector Laboratories, Peterborough, UK).
Prion exposure and disease monitoring
For i.c. or i.p. exposure mice were injected with 20 ml of a 1% (v/
w) scrapie brain homogenate prepared from mice terminally-
affected with ME7 scrapie prions (containing approximately 16104
i.c. ID50 units). Following exposure, mice were coded and assessed
blindly for signs of clinical disease and culled at a standard clinical
endpoint [64]. Survival times were recorded for mice that did not
develop clinical signs of disease and were culled when they showed
signs of intercurrent disease. Scrapie diagnosis was confirmed
blindly on coded sections by histopathological assessment of
vacuolation in the brain. For the construction of lesion profiles,
vacuolar changes were scored in nine grey-matter areas of brain as
described [65]. Where indicated, some four mice from each group
were culled at the times indicated post injection with scrapie and
tissues taken for further analysis. For bioassay of scrapie agent
infectivity, individual half spleens were prepared as 10% (wt/vol)
homogenates in physiological saline. Groups of four tga20 indicator
mice were injected i.c. with 20 ml of each homogenate. The scrapie
titre in each sample was determined from the mean incubation
period in the indicator mice, by reference to a dose/incubation
period response curve for ME7 scrapie-infected spleen tissue serially
titrated in tga20 mice using the relationship: y= 9.4533–0.0595x
(y, = log ID50 U/20 ml of homogenate; x, incubation period;
R2 = 0.9562). As the expression level of cellular PrPc controls the
prion disease incubation period, tga20 mice overexpressing PrPc are
extremely useful as indicator mice in prion infectivity bioassays as
they succumb to disease with much shorter incubation times than
conventional mouse strains [63].
IHC and immunofluorescent analyses
Spleens were removed and snap-frozen at the temperature of
liquid nitrogen. Serial frozen sections (10 mm in thickness) were cut
on a cryostat and immunostained with the following antibodies:
FDCs were visualized by staining with mAb 7G6 to detect CR2/
CR1 (CD21/CD35; BD Biosciences PharMingen), mAb FDC-M2
to detect C4 (AMS Biotechnology, Oxon, UK) or mAb 8C12 to
detect CR1 (CD35; BD Biosciences PharMingen). Cellular PrPC
was detected using PrP-specific polyclonal antibody (pAb) 1B3 [66].
B cells were detected using mAb B220 to detect CD45R (Caltag,
Towcester, UK), or anti-CD19 (BD biosciences PharMingen).
Marginal zone B cells were detected using mAb 1B1 to detect CD1d
(BD Biosciences PharMingen). Sympathetic nerves were detected
using tyrosine hydroxylase (TH)-specific pAb (Chemicon Europe).
For the detection of disease-specific PrP (PrPd) in spleens and
brains, tissues were fixed in periodate-lysine-paraformaldehyde
fixative and embedded in paraffin wax. Sections (thickness, 6 mm)
were deparaffinised, and pre-treated to enhance the detection of
PrPd by hydrated autoclaving (15 min, 121uC, hydration) and
subsequent immersion formic acid (98%) for 5 min [67]. Sections
were then immunostained with 1B3 PrP-specific pAb. For the
detection of EGF-like module-containing mucin-like hormone
receptor-like 1 (EMR1)-expressing macrophages, paraffin-embed-
ded spleen sections were micro-waved in citric acid buffer (pH 6.0)
for 10 min. Endogenous peroxidase activity was blocked using 1%
hydrogen peroxidase in methanol, and macrophages detected
using rat mAb F4/80 to detect EMR1 (clone CI:A3-1, AbD
Serotec). For the detection of astrocytes, brain sections were
immunostained with anti-glial fibrillary acidic protein (GFAP;
DAKO, Ely, UK). For the detection of microglia, deparaffinised
brain sections were first pre-treated with Target Retrieval Solution
(DAKO) and subsequently immunostained with anti-ionized
calcium-binding adaptor molecule 1 (Iba-1; Wako Chemicals
GmbH, Neuss, Germany). Immunolabelling was revealed using
HRP-conjugated to the avidin-biotin complex (Novared kit,
Vector laboratories, Peterborough, UK). Paraffin-embedded tissue
(PET) immunoblot analysis was used to confirm the PrPd detected
by immunohistochemistry was proteinase K (PK)-resistant PrPSc
[34]. Membranes were subsequently immunostained with 1B3
PrP-specific pAb.
For light microscopy, following the addition of primary
antibodies, biotin-conjugated species-specific secondary antibodies
(Stratech, Soham, UK) were applied followed by alkaline
phosphatase or HRP coupled to the avidin/biotin complex
(Vector Laboratories). Vector Red (Vector Laboratories) and
diaminobenzidine (DAB; Sigma Aldrich, Dorset, UK) were used
as substrates, respectively, and sections were counterstained with
haematoxylin to distinguish cell nuclei. For fluorescent microsco-
py, following the addition of primary antibody, species-specific
secondary antibodies coupled to Alexa Fluor 488 (green), Alexa
Fluor 594 (red) dyes or Alexa Fluor 647 (blue) dyes (Invitrogen,
Paisley, UK) were used. Sections were mounted in fluorescent
Table 1. PCR primers used to confirm the genotypes of mice
used in this study.
Allele Details Primer sequence Product size/s (bp)
Cre Fwd CGAGTGATGAGGTTCGCAAGAACC 786
Rev GCTAAGTGCCTTCTCTACACCTGC 300
LacZ Fwd TACCACAGCGGATGGTTCGG 300
Rev GTGGTGGTTATGCCGATCGC
Prnpflox 1 AATGGTTAAACTTTCGTTAAGGAT Prnpde-flox 344
2 GCCGACATCAGTCCACATAG Prnpflox 210
3 GGTTGACGCCATGACTTTC PrnpWT 167
Prnpnull Fwd GCCATCACGAGATTTCGATT 1,200
Rev ATCCCACGATCAGGAAGATG
PrnpWT Fwd TCATCCCACGATCAGGAAGATGAG 600
Rev ATGGCGAACCTTGGCTACTGGCTG
Prnpstop 1 ACAAATGTGGTATGGCTGATTATG Prnpstop 1,000
2 ATGATGATTGAACAAGATGGATTG Prnpstop(R) 840
3 TACCACGAAGTCCGGGATAG PrnpWT 750
4 GGCAGAGGCTAAGGACAACA
Fwd, forward primer; Rev, reverse primer; (R), Cre-mediated DNA recombined
allele.‘
doi:10.1371/journal.ppat.1002402.t001
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mounting medium (DakoCytomation) and examined using a Zeiss
LSM5 confocal microscope (Zeiss, Welwyn Garden City, UK).
Image analysis
Digital microscopy images were analyzed using ImageJ software
(http://rsbweb.nih.gov/ij/) as described [68]. Intensity thresholds
were first applied and then the number of pixels of each colour
(black, red, green, yellow) were then automatically counted and
presented as a proportion of the total number of pixels in each
area under analysis. The preferential co-localisation of fluoro-
chromes was determined by comparisons of the observed
distribution of colours with those predicted by the null hypothesis
that each element of positive staining was randomly and
independently distributed. Values found to be significantly greater
than the null hypothesis confirm significant co-localisation of
fluorochromes. Spleens from 6 mice from each group were
analyzed. From each spleen, 2 sections were studied and on each
section data from 4 individual FDC networks collected. Thus, for
each mouse group data from a total of 48 individual FDC were
analysed. Similarly, data from 48 images from each group were
analyzed to determine the preferential co-localisation of fluoro-
chromes upon TH-positive sympathetic nerves within the spleen.
A one-way ANOVA test was then used to compare the null
hypothesis (that the pixels were randomly distributed) to the
observed levels of co-localisation.
Passive immunization
To assess antigen trapping by FDC in vivo, mice were passively
immunized by intravenous injection with 100 ml preformed PAP
immune complexes (Sigma). Spleens were removed 24 h later and
the presence of FDC-associated immune complexes identified by
IHC.
Statistical analyses
Data are presented as mean 6 SE. Unless indicated otherwise,
significant differences between samples in different groups were
sought by one-way ANOVA. Values of P,0.05 were accepted as
significant.
Supporting Information
Figure S1 In the absence of PrPC expression by
follicular dendritic cells prions are scavenged by
tingible body macrophages in the spleen. Mice were
injected i.p. with ME7 scrapie prions. Spleens from CD21-Cre
Prnpstop/-RPrnpstop/- mice (in which cellular PrPC was expressed
only on B cells, upper row), Prnpflox/-RCD21-Cre Prnpflox/- mice
(with FDC-restricted PrPC ablation, middle row) and CD21-Cre
Prnpflox/-RCD21-Cre Prnpflox/- mice (in which PrPC expression
was ablated on FDC and B cells, lower row) were collected 70 days
after i.p. infection. Due to the absence of PrPC-expressing FDC
prion replication in these tissues was blocked. However, in the
spleens of some of these mice, low levels of PrPd (left-hand column,
red) were occasionally localised within cells with characteristics
typical of tingible body macrophages. These cells contained the
remnants of many phagocytosed apoptotic lymphocytes (tingible
bodies, arrowheads) and expressed the tissue macrophage marker
EGF-like module-containing mucin-like hormone receptor-like 1
(EMR1) detected by mAb F4/80 (right-hand column, brown).
Data are representative of spleens from at least 4 mice from each
group. Sections are counterstained with haematoxylin (blue). Scale
bar, 20 mm.
(PDF)
Figure S2 Follicular dendritic cell-specific PrPc expres-
sion alone is sufficient to sustain high levels of prion
infectivity in the spleen. Prion infectivity levels were assayed
spleens from control mice (Prnp+/-RPrnpflox/- mice), Prnpstop/-
RCD21-Cre Prnpstop/- mice in which cellular PrPC was expressed
only on FDC and Prnpflox/-RCD21-Cre Prnpflox/- mice with FDC-
restricted PrPC ablation (n= 3/group) collected 70 days after i.p.
with ME7 scrapie prions. Prion infectivity titres were determined
by transmission of tissue homogenates into groups of 4 indicator
tga20 mice. Each point represents data derived from an individual
spleen. Data below the horizontal line indicate disease incidence in
the recipient mice ,100% and considered to contain trace levels
of prion infectivity. High levels of prion infectivity were detected in
spleens of control mice and those in which cellular PrPC was
expressed only on FDC (left-hand and middle panels, respectively).
However, this accumulation was blocked in spleens with FDC-
restricted PrPC ablation as only trace levels of infectivity were
detected (right-hand panel).
(PDF)
Figure S3 Effect of FDC-restricted PrPC-ablation on
disease pathogenesis within the brain after i.p. prion
exposure. Mice were injected i.p. with ME7 scrapie prions.
Brains were collected from clinically scrapie-affected mice and
mice which were free of the clinical signs of prion disease at the
time of cull and the neuropathology within each brain
compared. High levels of spongiform pathology (H&E, upper
row), heavy accumulations of PrPd (brown, second row), reactive
astrocytes expressing GFAP (brown, third row) and active
microglia expressing Iba-1 (brown, bottom row) were detected
in the hippocampi of the brains of all clinically scrapie-affected
control mice (right-hand column, n = 5) and mice in which PrPC
expression was ablated in B cells only (CD21-Cre
Prnpflox/-RPrnpflox/- mice, third column, n = 3). In contrast,
none of the mice with PrPC-ablated FDC (FDC-restricted,
Prnpflox/-RCD21-Cre Prnpflox/- mice, first column, n = 6; FDC
and B cells, CD21-Cre Prnpflox/-RCD21-Cre Prnpflox/- mice,
second column, n = 7) developed clinical signs of prion disease
during their life-spans or histopathological signs of prion disease
in their brains. Scale bar, = 500 mm. Clin., presence of clinical
signs of scrapie at the time of cull; Path., histopathological
detection of spongiform pathology in the brain; dpi, days post
i.p. prion infection.
(PDF)
Table S1 Effect of FDC-restricted Prnp ablation on
prion disease pathogenesis after i.p. exposure.
(DOCX)
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